Short Interest in Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Rises By 302.9%

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKFGet Free Report) saw a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 31,081 shares, a growth of 302.9% from the August 15th total of 7,714 shares. Based on an average daily volume of 832 shares, the days-to-cover ratio is presently 37.4 days.

Fisher & Paykel Healthcare Price Performance

Shares of Fisher & Paykel Healthcare stock opened at $25.79 on Monday. Fisher & Paykel Healthcare has a twelve month low of $19.01 and a twelve month high of $26.53. The firm’s 50-day moving average price is $24.13 and its 200 day moving average price is $23.07.

Analyst Upgrades and Downgrades

Separately, Citigroup upgraded Fisher & Paykel Healthcare to a “buy” rating in a research report on Thursday. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Get Our Latest Research Report on Fisher & Paykel Healthcare

About Fisher & Paykel Healthcare

(Get Free Report)

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.

Further Reading

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.